The Relationship of Serum 25-Hydroxyvitamin D Levels with Disease Activity in Upper Egyptian Patients with Rheumatoid Arthritis

Ahmed, Abdullah; Allam, Ahmed

doi:10.21608/smj.2018.41100

The Relationship of Serum 25-Hydroxyvitamin D Levels with Disease Activity in Upper Egyptian Patients with Rheumatoid Arthritis

Document Type : Original Article

Authors

Abdullah Ahmed ¹
Ahmed Allam ²

¹ Department of Rheumatology and Rehabilitation, Faculty of Medicine, Sohag University, Egypt.

² Department of Clinical Pathology, Faculty of Medicine, Sohag University, Egypt.

10.21608/smj.2018.41100

Abstract

Aim of the work: To assess the serum 25-hydroxyvitamin D concentrations [25(OH)D] and their relationship with parameters of disease activity in upper Egyptian patients with rheumatoid arthritis (RA).
Patients and methods: A case-control study was made on 34 patients with RA and 34 healthy control subjects. The following values were assessed for each patient: erythrocyte sedimentation rate (ESR), C reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (Anti-CCP), visual analogue scale of pain (VAS), disease activity score 28 (DAS28), and serum 25-hydroxyvitamin D concentrations.
Results: Patients with RA had mild to moderate (DAS28 ˂ 5.1) disease activity. The mean serum level of 25(OH)D in patients with RA (24.35±5.66 ng/ml) was significantly lower (P˂ 0.001) than controls (42.46±11.33 ng/ml). Serum 25(OH)D levels did not show correlation with disease duration, ESR, CRP, VASor DAS28 in patients with RA.Serum 25(OH)D levels were significantly correlated with age in RA patients (P˂ 0.01).Serum 25(OH)D levels had no relation to RF or anti-CCP positivity.
Conclusion: Although serum 25(OH)D levels were lower in RA patients of upper Egypt, there was no correlation with disease activity parameters, therefore, serum 25(OH)D concentrations cannot be used to reflect disease activity.

Keywords

References

1. Jeffery LE, Raza K, Hewison M. Vitamin D in rheumatoid arthritis-towards clinical application. Nature reviews Rheumatology. 2016;12(4):201-10.

2. Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nature reviews Drug discovery. 2016;15(5):305-6.

3. Hall AC, Juckett MB. The role of vitamin D in hematologic disease and stem cell transplantation. Nutrients. 2013;5(6):2206-21.

4. Gulko PS, Winchester RJ. Rheumatoid arthritis. . In: Samter’s Immunologic Diseases Austen KF, Frank MM, Atkinson JP, Cantor H (eds) Lippincott, Williams & Wilkins, Baltimore, MD. 2001:427-63.

5. Lin J, Liu J, Davies ML, Chen W. Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis. PLoS One. 2016;11(1):e0146351.

6. Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Gurman A. Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatology international. 2011;31(4):493-9.

7. Craig SM, Yu F, Curtis JR, Alarcon GS, Conn DL, Jonas B, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. The Journal of rheumatology. 2010;37(2):275-81.

8. Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology. 2014;53(11):1994-2001.

9. Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Therapeutic advances in endocrinology and metabolism. 2012;3(6):181-7.

10. Racovan M, Walitt B, Collins CE, Pettinger M, Parks CG, Shikany JM, et al. Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women's Health Initiative Calcium plus Vitamin D trial. Rheumatology international. 2012;32(12):3823-30.

11. Rossini M, Maddali Bongi S, La Montagna G, Minisola G, Malavolta N, Bernini L, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis research & therapy. 2010;12(6):R216.

12. Sahebari M, Mirfeizi Z, Rezaieyazdi Z, Rafatpanah H, Goshyeshi L. 25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DA S28 ESR). Caspian journal of internal medicine. 2014;5(3):148-55.

13. Turhanoglu AD, Guler H, Yonden Z, Aslan F, Mansuroglu A, Ozer C. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatology international. 2011;31(7):911-4.

14. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the rheumatic diseases. 2010;69(9):1580-8.

15. Mallya RK, Mace BE. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatology and rehabilitation. 1981;20(1):14-7.

16. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44-8.

17. Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, et al. The complex role of vitamin D in autoimmune diseases. Scandinavian journal of immunology. 2008;68(3):261-9.

18. Gatenby P, Lucas R, Swaminathan A. Vitamin D deficiency and risk for rheumatic diseases: an update. Current opinion in rheumatology. 2013;25(2):184-91.

19. Haque UJ, Bartlett SJ. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clinical and experimental rheumatology. 2010;28(5):745-7.

20. Dong H, Xu L, Bi L. [An investigation on vitamin D levels in peripheral blood in rheumatoid arthritis]. Wei sheng yan jiu = Journal of hygiene research. 2012;41(2):313-5.

21. Gheita TA, Sayed S, Gheita HA, Kenawy SA. Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. International journal of rheumatic diseases. 2016;19(3):294-9.

22. Attar SM. Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia. Saudi medical journal. 2012;33(5):520-5.

23. Pakchotanon R, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P. The association between serum vitamin D Level and disease activity in Thai rheumatoid arthritis patients. International journal of rheumatic diseases. 2016;19(4):355-61.

24. Matsumoto Y, Sugioka Y, Tada M, Okano T, Mamoto K, Inui K, et al. Relationships between serum 25-hydroxycalciferol, vitamin D intake and disease activity in patients with rheumatoid arthritis--TOMORROW study. Modern rheumatology / the Japan Rheumatism Association. 2015;25(2):246-50.

25. Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmunity reviews. 2011;11(2):84-7.

26. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. The Journal of nutrition. 1998;128(1):68-72.

27. Moghimi J, Sadeghi A, Malek M, Ghorbani R. Relationship between disease activity and serum levels of vitamin D and parathyroid hormone in rheumatoid arthritis. Endocrine regulations. 2012;46(2):61-6.